Americas Sleep Apnea Market is expected to reach US$ 4,103.24 million by 2030

Publisher: The Insight Partners

Therapeutic Segment to Account for Largest Share in Americas Sleep Apnea Market During 2022–2030

According to our latest study on “Americas Sleep Apnea Market Forecast to 2028 – COVID-19 Impact and Analysis – by Type, End User, and Country," the market is expected to grow from US$ 2,454.20 million in 2022 to US$ 4,103.24 million by 2030; it is expected to grow at a CAGR of 6.6% from 2022 to 2030. The report highlights the key factors driving the market growth and prominent players with their developments in the market.

Growing Demand for Sleep Apnea Diagnostic Devices and Therapeutic Solutions Boosts Market Growth

Medical devices are essential for the prevention, diagnosis, treatment, and rehabilitation of a medical condition. The medical device industry is witnessing continuous innovations and technological advancements, which, in turn, is driving the healthcare sector in the Americas. Polysomnography (PSG) devices, home sleep testing devices, oximeters, actigraphy monitoring devices, and sleep apnea screening devices are the most widely used diagnostic devices for the diagnosis and assessment of sleep disorders.

Americas Sleep Apnea Market, by Country, 2022 (%)
 To get free sample copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/sample/TIPRE00030024

Source: The Insight Partners Analysis

According to the American Academy of Sleep Medicine report, a study conducted and reviewed by the Minnesota Regional Sleep Disorders Center showed a high rate of depression among people suffering from obstructive sleep apnea (OSA) in both community and clinical settings. Fatigue and drowsiness are the two main OSA symptoms associated with mental health conditions. Additionally, data published in the American Journal of Epidemiology reveals that the estimated prevalence rates of OSA have substantially increased over the last two decades, majorly due to epidemic obesity. It is further estimated that 26% of adults in the US aged between 30 and 70 years suffer from sleep apnea. According to a neuroimaging study published in the Journal Sleep article, the participants suffering from severe, untreated sleep apnea had a significant reduction in white matter fiber integrity in multiple brain areas, accompanied by the impairment of cognition, mood, and daytime alertness. However, following one year of continuous positive airway pressure (CPAP) therapy, patients have witnessed recovery from brain damage. Thus, the growing demand for sleep apnea diagnostic devices and therapeutic solutions is driving the sleep apnea market growth.

Technological Developments to Bring New Trends in Sleep Apnea Market in Future
Technological advancements and awareness regarding sleep apnea are boosting the adoption of various medical devices, such as PSG and home sleep testing. Many industry players are focusing on innovative product strategies to meet the growing demand for sleep apnea diagnostic devices. For instance, in August 2021, ResMed successfully launched "AirSense 11," the first available in the US. It is the company's next-generation positive airway pressure device designed to assist people suffering from sleep apnea. In August 2020, Nihon Koden Corporation announced the launch of Polysmith 12 polysomnography software. The Polysmith software includes more than 40 market-driven features that allow sleep specialists to improve workflow, analysis, and outcomes of the sleep apnea medical device. The new product also offers a cost-effective design with a broad range of features, such as the enhancement of scheduling, prioritization, and e-mail notification capabilities providing better workflow, improved status tracking to categorize patients based on priority and status, and the ability to track patient progress to improve clinical outcomes.

ResMed Inc, Nihon Kohden Corp, Fisher & Paykel Healthcare Ltd, Koninklijke Philips NV, Cadwell Industries Inc, Natus Medical Inc, Compumedics Limited, LivaNova Plc, Invacare Corp, and Braebon Medical Corporation are among the leading companies operating in the Americas sleep apnea market.    

Various organic and inorganic strategies are adopted by companies operating in the Americas sleep apnea market. Organic strategies mainly include product launches and product approvals. Further, acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall market growth. Further, acquisition and partnership strategies help the market players strengthen their customer base and expand their product portfolios. A few of the significant developments by key players operating in the Americas sleep apnea market are listed below.

• In July 2023, ResMed acquired Somnoware. Through this acquisition, ResMed will expand its sleep management software solution to allow sleep labs and physicians to guide their patients into and through diagnosis to long-term treatment with greater efficiency.
• In April 2020, Cadwell Industries, Inc. reintroduced the ApneaTrak home sleep apnea testing (HSAT) device, with three models to meet multiple levels of clinical needs to help diagnose sleep apnea and test the efficacy of treatments.

Contact Us
Contact Us: The Insight Partners 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com